GSK plc
SEC CIK 1131399 · EDGAR
BoughtSold
Most active insiders at WVE, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | RA CAPITAL MANAGEMENT, L.P. | Dir, 10% | $54.63M | — |
| 2 | GSK plc | 10% | $27.93M | — |
| 3 | Francis Chris | See Remarks | — | $7.10M |
| 4 | Moran Kyle | CFO | — | $4.15M |
| 5 | Tan Aik Na | Dir | — | $1.83M |
| 6 | HENRY CHRISTIAN O | Dir | — | $1.37M |
| 7 | Rawcliffe Adrian | Dir | — | $806.6K |
| 8 | Verdine Gregory L. | Dir | — | $269.5K |
| 9 | Wagner Heidi L | Dir | — | $231.1K |
| 10 | CORRIGAN MARK | Dir | — | $217.3K |
Transactions 6
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2025-12-15 | 2025-12-11 | WVE | Wave Life Sciences, Inc. | GSK plc | 10% | P - Purchase | $19.00 | +1.47M | 18.25M | +9% | +$27.93M |
| I | 2024-10-01 | 2024-09-27 | WVE | Wave Life Sciences, Inc. | GSK plc | 10% | P - Purchase | $8.00 | +2.79M | 16.78M | +20% | +$22.34M |
| I | 2024-01-30 | 2023-12-07 | WVE | Wave Life Sciences, Inc. | GSK plc | 10% | P - Purchase | $5.00 | +3.30M | 13.98M | +31% | +$16.50M |
| DI | 2022-09-20 | 2022-09-16 | TBPH | Theravance Biopharma, Inc. | GSK PLC | Former 10% Owner | J - Other | $9.75 | -9.64M | 0 | -100% | -$94.04M |
| DMI | 2021-07-06 | 2021-07-02 | CVRX | CVRx, Inc. | GLAXOSMITHKLINE PLC | 10% | C - Cnv Deriv | — | +700.8K | 732.6K | +2,203% | — |
| DI | 2021-07-06 | 2021-07-02 | CVRX | CVRx, Inc. | GLAXOSMITHKLINE PLC | 10% | P - Purchase | $18.00 | +275.0K | 1.01M | +38% | +$4.95M |
Purchase Sale Sale after option exercise All abbreviations